FSM Wealth Advisors LLC Has $1.84 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

FSM Wealth Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,504 shares of the healthcare conglomerate’s stock after selling 57 shares during the quarter. FSM Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,835,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the stock. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its stake in shares of UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in UnitedHealth Group by 1.6% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 121,738 shares of the healthcare conglomerate’s stock worth $61,583,000 after acquiring an additional 1,906 shares during the period. Finally, WMG Financial Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $585,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares of the company’s stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Corporate insiders own 0.28% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of a number of research analyst reports. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Baird R W lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Oppenheimer cut their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Finally, TD Securities reaffirmed a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $415.57.

UnitedHealth Group Stock Up 4.4%

Shares of NYSE UNH opened at $325.83 on Wednesday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market capitalization of $295.57 billion, a P/E ratio of 13.64, a PEG ratio of 1.48 and a beta of 0.45. The firm’s 50 day simple moving average is $331.91 and its two-hundred day simple moving average is $451.20. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.71%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.